このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Medpace Holdings 過去の業績
過去 基準チェック /66
Medpace Holdingsは、平均年間25.7%の収益成長を遂げていますが、 Life Sciences業界の収益は、年間 成長しています。収益は、平均年間16.8% 19.9%収益成長率で 成長しています。 Medpace Holdingsの自己資本利益率は46.5%であり、純利益率は15.9%です。
主要情報
25.2%
収益成長率
29.0%
EPS成長率
Life Sciences 業界の成長 | 21.5% |
収益成長率 | 20.3% |
株主資本利益率 | 44.5% |
ネット・マージン | 16.7% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Oct 10Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 26Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Aug 28収支内訳
収支内訳
Medpace Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 2,030 | 340 | 169 | 0 |
31 Mar 24 | 1,963 | 312 | 167 | 0 |
31 Dec 23 | 1,886 | 283 | 161 | 0 |
30 Sep 23 | 1,782 | 273 | 152 | 0 |
30 Jun 23 | 1,673 | 268 | 146 | 0 |
31 Mar 23 | 1,563 | 257 | 140 | 0 |
31 Dec 22 | 1,460 | 245 | 131 | 0 |
30 Sep 22 | 1,374 | 227 | 126 | 0 |
30 Jun 22 | 1,286 | 209 | 118 | 0 |
31 Mar 22 | 1,213 | 199 | 112 | 0 |
31 Dec 21 | 1,142 | 181 | 108 | 0 |
30 Sep 21 | 1,094 | 182 | 103 | 0 |
30 Jun 21 | 1,028 | 175 | 98 | 0 |
31 Mar 21 | 955 | 159 | 93 | 0 |
31 Dec 20 | 926 | 145 | 92 | 0 |
30 Sep 20 | 896 | 124 | 91 | 0 |
30 Jun 20 | 882 | 107 | 97 | 0 |
31 Mar 20 | 891 | 110 | 99 | 0 |
31 Dec 19 | 861 | 100 | 95 | 0 |
30 Sep 19 | 823 | 93 | 95 | 0 |
30 Jun 19 | 786 | 88 | 84 | 0 |
31 Mar 19 | 742 | 78 | 81 | 0 |
31 Dec 18 | 705 | 73 | 76 | 0 |
30 Sep 18 | 612 | 61 | 72 | 0 |
30 Jun 18 | 531 | 52 | 70 | 0 |
31 Mar 18 | 456 | 45 | 64 | 0 |
31 Dec 17 | 386 | 39 | 63 | 0 |
30 Sep 17 | 382 | 28 | 63 | 0 |
30 Jun 17 | 379 | 23 | 63 | 0 |
31 Mar 17 | 377 | 18 | 63 | 0 |
31 Dec 16 | 371 | 13 | 62 | 0 |
30 Sep 16 | 361 | 5 | 65 | 0 |
30 Jun 16 | 348 | 0 | 60 | 0 |
31 Mar 16 | 332 | -5 | 57 | 0 |
31 Dec 15 | 320 | -9 | 54 | 0 |
31 Dec 14 | 290 | -16 | 40 | 0 |
31 Dec 13 | 244 | 25 | 35 | 0 |
質の高い収益: MEDPは 高品質の収益 を持っています。
利益率の向上: MEDPの現在の純利益率 (16.7%)は、昨年(16%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: MEDPの収益は過去 5 年間で年間25.7%増加しました。
成長の加速: MEDPの過去 1 年間の収益成長率 ( 26.5% ) は、5 年間の平均 ( 年間25.2%を上回っています。
収益対業界: MEDPの過去 1 年間の収益成長率 ( 21.6% ) はLife Sciences業界-6.5%を上回りました。
株主資本利益率
高いROE: MEDPの 自己資本利益率 ( 46.5% ) は 傑出している と考えられます。